Purpose of review: To summarize the most current literature on transplant outcomes in HIV-infected kidney recipients.
Recent findings: HIV-infected recipients overall have excellent patient and allograft outcomes. Acute rejection, delayed graft function, drug-drug interactions and limited access to organs have emerged as important issues for HIV-infected kidney transplant patients. The subset of patients who are coinfected with hepatitis C virus do not fare as well and improving their outcomes should be a focus of future research in the field.
Summary: Renal transplantation remains the optimal treatment for end stage renal disease in the HIV-infected patient.